NASDAQ · LGND
Ligand Pharmaceuticals Incorporated
$317.33-$1.45 (-0.45%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
Loading market information…
OTC · OXIHF · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Oxford Investments Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Oxford Investments Holdings, Inc. engages in managed transaction processing service solutions business. It offers corporations electronic transaction payments processing services. The company was founded by Michael Donaghy on October 13, 2000 and is headquartered in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$317.33-$1.45 (-0.45%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
$0.06+$0.01 (+11.98%)
CTT Pharmaceutical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.1% below the high.
$0.04$0.00 (0.0%)
Telesis Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.27% below the high.
$0.07-$0.11 (-62.17%)
Eco Science Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.38% below the high.
$0.00$0.00 (0.0%)
RushNet, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Neutra Corp.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
$0.00$0.00 (0.0%)
Opus Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.02-$0.00 (-8.26%)
China Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
